[Decrease of hematic bradykininogen during antiblastic chemotherapy].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001920:Bradykinin / Q000097:blood*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D014363:Tryptamines / Q000652:urine*
D000970:Antineoplastic Agents; D014363:Tryptamines; D001920:Bradykinin
Diminuzione del bradichininogeno ematico in corso di chemioterapia antiblastica.